The global blood collection market is expected to reach a value of USD
13.3 billion by 2025, according to a new report by Grand View Research, Inc.
The increasing incidence of infectious and non-communicable diseases is a major
factor anticipated to propel the market growth during the forecast period.
According to the Centers for Disease Control and Prevention (CDC), in 2013,
around 19.3 million people visited the physician’s clinic for infectious and
parasitic diseases testing in the U.S. Moreover, according to International
Diabetes Federation, 415 million people suffered from diabetes in 2014 and this
number is expected to rise up to 642 million by 2040. Thus, the increasing
incidence of accidents and trauma cases is another factor that drives the demand
for blood collection products for therapeutic application.
 |
North America blood collection market share, by
application, 2015
|
The increasing number of surgical procedures is an additional key factor
contributing to the growth. The escalating number of accidental injury cases is
expected to propel the demand for target market products for therapeutics
application. According to the CDC, in the U.S, around 31.0 million patients
visited emergency centers for unintentional injuries in 2014. Thus, the demand
for blood collection products such as bags, needles, and syringes is growing at
a high rate, which is expected to boost the growth during the forecast period.
In depth research report on Blood Collection Market
Further Key
Findings from the Study Suggest:
·
The needles
and syringes segment was the largest grossing segment of the blood collection
market in 2015 owing to the growing application of these devices in diagnosis
and treatment of various disorders like diabetes and blood-related diseases
·
The
diagnostics application segment held the largest revenue share in 2015, owing
to rising geriatric population and escalating prevalence of infectious &
non-communicable diseases
·
In 2015, the
hospitals segment accounted for the largest share in the market due to an
upsurge in the incidence of trauma & accidental cases along with growing
number of surgical procedures
·
North America
held the largest share of the blood collection market in the year 2015. This
region is estimated to uphold its dominance during the study period
·
The presence
of a highly developed healthcare infrastructure and advanced blood collection
products is anticipated to boost the growth in North America during the
forecast period
·
Some of the
key companies include Abbott Laboratories, NIPRO Medical Corp., Becton,
Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.
Grand View Research has segmented the blood collection market on the
basis of product, application, end-use, and region:
Blood Collection Product Outlook (Revenue, USD
Million; 2014 - 2025)
·
Needles and
Syringes
·
EDTA Tubes
·
Heparin Tubes
·
Serum-Separating
Tubes
·
Plasma-Separating
Tubes
·
Blood Bags
·
Others
Blood Collection Application Outlook (Revenue,
USD Million; 2014 - 2025)
·
Diagnostics
·
Treatment
Blood Collection End-Use Outlook (Revenue, USD
Million; 2014 - 2025)
·
Hospitals
·
Diagnostics
centers
·
Blood banks
·
Others
Blood Collection Regional Outlook (Revenue,
USD Million; 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
India
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
For more
market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment